XtalPi (HKG:2228) has received approval from the Hong Kong Stock Exchange to be regarded as a "commercial company" as opposed to a "pre-commercial company" previously.
Following the approval, the biotechnology firm will no longer have the "P" marker affixed to its English and Chinese stock short name. The new English stock short name will be XTALPI.